A dataset of original image for Western Blot in manuscript of Network Pharmacology Prediction and Experiment Validation to Discover the Mechanism of Sophora Japonica Linn against Liver Cancer

In vitro biological experiments showed that isorhamnetin and quercetin, the main active components of Sophora japonica Linn, had significant inhibitory effect on liver cancer cells HepG2. In addition, the expression of AKT and MEK proteins was downregulated, which proved that both isorhamnetin and quercetin promoted apoptosis by activating the PI3K/AKT and MAPK signaling pathways. In summary, our findings clarify the inhibitory effect of the active ingredients of Sophora japonica Linn against HepG2 cells and provide inspiration for its clinical application in the treatment of liver cancer.